Search results for "rex"

showing 10 items of 701 documents

Lielbritānijas izstāšanās no Eiropas Savienības potenciālās sekas uz Lielbritānijas ekonomikas būtiskākajiem rādītājiem un valūtas tirgu

2017

Bakalaura darbā “Lielbritānijas izstāšanās no Eiropas Savienības potenciālās sekas uz Lielbritānijas ekonomikas būtiskākajiem rādītājiem un valūtas tirgu” tiek identificēti vairāki potenciālie Lielbritānijas izstāšanās no Eiropas Savienības scenāriji un to iespējamās sekas uz Lielbritānijas ekonomiku un valūtas tirgu. Darbā tiek noskaidroti galvenie izstāšanās scenāriji, arī tas, ko Lielbritānija no tiem iegūs un zaudēs, kā arī ekonomiskās sekas, ko katrs no šiem scenārijiem atstās. Darbā tiek analizēts Lielbritānijas ekonomikas stāvoklis un pētīts, kādu ietekmi uz to atstājis ir referendums par izstāšanos no Eiropas Savienības. Tāpat tiek analizēta Londonas kā pasaules finanšu centra nozīm…

LielbritānijaValūtas tirgusEiropas SavienībaFinanšu centrsEkonomikaBrexit
researchProduct

Selective Processing of Food– and Body–Related Information and Autonomic Arousal in Patients with Eating Disorders

1998

Both attentional bias (using the modified Stroop Task) and autonomic reactivity (skin conductance level) to food- and body-related information were assessed in 25 patients with eating disorders (15 patients with anorexia, 10 patients with bulimia) and 18 women controls. Patients with anorexia showed the greatest interference in color-naming food-related words. However, on this occasion there were no differences in body condition, probably because of heterogeneity of clinical samples and because the control group were staff members, so the target information was very familiar to them. The groups differed in their autonomic reactivity while performing the Stroop, the patients with anorexia re…

Linguistics and Languagemedicine.medical_specialtyAutonomic arousaldigestive oral and skin physiologyAnorexiaAttentional biasAudiologymedicine.diseaseLanguage and LinguisticsCognitive biasDevelopmental psychologyEating disordersmental disordersmedicineIn patientmedicine.symptomPsychologyReactivity (psychology)General PsychologyStroop effectThe Spanish Journal of Psychology
researchProduct

Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: A decision tree for clini…

2009

Objective To survey rheumatologists' preferences for the choice of a second-line disease-modifying antirheumatic drug (DMARD) after inadequate response with methotrexate (MTX) therapy in rheumatoid arthritis (RA). Methods Thirty-six rheumatologists stated their preferences for RA treatment after inadequate response with MTX therapy (optimal dose at least 6 months). From the initial scenario, we derived 54 vignettes varying by rheumatoid factor or anti–cyclic citrullinated peptide antibody presence, swollen joint count, Disease Activity Score in 28 joints, and structural damage. Respondents stated their preference among 5 therapeutic options: MTX continuation, switch to another conventional …

MESH: Antirheumatic AgentsMESH: Decision TreesMESH: Treatment FailureArthritisMESH: Antibodies Anti-IdiotypicMESH: Logistic ModelsLogistic regressionSeverity of Illness IndexArthritis Rheumatoid0302 clinical medicineimmune system diseasesImmunology and AllergyMESH: Data CollectionPharmacology (medical)Treatment Failure030212 general & internal medicinePractice Patterns Physicians'skin and connective tissue diseasesMESH: Arthritis RheumatoidData CollectionAntibodies Anti-Idiotypic3. Good healthMESH: Interleukin 1 Receptor Antagonist ProteinMESH: Methotrexate[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal systemAntirheumatic AgentsRheumatoid arthritismedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyMESH: Rheumatoid FactorImmunologyPeptides Cyclic03 medical and health sciencesRheumatologyRheumatoid FactorMESH: Severity of Illness IndexInternal medicineSeverity of illnessmedicineHumansRheumatoid factorMESH: Physician's Practice PatternsMESH: Peptides Cyclic030203 arthritis & rheumatologyAnakinraMESH: HumansTumor Necrosis Factor-alphabusiness.industryDecision Treesmedicine.diseaseRheumatologyInterleukin 1 Receptor Antagonist ProteinLogistic ModelsMethotrexateMESH: Tumor Necrosis Factor-alphaPhysical therapyMethotrexatebusinessArthritis & Rheumatism
researchProduct

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' fi…

2006

International audience; BACKGROUND: The objective was to develop a clinical practice format for choosing a second-line disease-modifying anti-rheumatic drug (DMARD) after a 6-month course of a first-line DMARD in patients with early RA. METHODS: A panel of 34 experts selected treatment option from various scenarios using the Thurstone pairwise method. The experts had to choose between two proposed DMARDs without proposing other options. The scenarios were obtained using the three items: DAS28, rheumatoid factor status and radiographic structural damage. A sample of 240 among 480 scenarios for each expert was taken at random. Responses given by at least 20% of the experts were considered per…

MESH: Antirheumatic AgentsMESH: Treatment FailureDiseaseReceptors Tumor Necrosis FactorEtanerceptArthritis Rheumatoid0302 clinical medicineMESH: Practice Guidelines as Topic030212 general & internal medicineTreatment Failureskin and connective tissue diseasesMESH: Immunoglobulin GMESH: Arthritis RheumatoidAnti rheumatic drugs3. Good healthClinical PracticeMESH: Methotrexate[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal systemRheumatoid arthritisAntirheumatic AgentsPractice Guidelines as TopicDrug Therapy CombinationLeflunomidemusculoskeletal diseasesmedicine.medical_specialtyMESH: Rheumatoid FactorFirst lineMESH: Drug Administration ScheduleDrug Administration ScheduleDecision Support Techniques03 medical and health sciencesRheumatologyRheumatoid FactorDmard therapymedicineRheumatoid factorHumansIntensive care medicine030203 arthritis & rheumatologyMESH: HumansMESH: Sulfasalazinebusiness.industryMESH: Biological MarkersMESH: Decision Support TechniquesEarly rheumatoid arthritisIsoxazolesmedicine.diseaseMESH: Receptors Tumor Necrosis FactorRadiographySulfasalazineMESH: Drug Therapy CombinationMethotrexateMESH: IsoxazolesImmunoglobulin GPhysical therapybusinessBiomarkersJoint bone spine
researchProduct

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.

2016

IF 10.383; International audience; OBJECTIVES: Cancer may be a complication of inflammatory bowel disease (IBD) or its treatment. In elderly onset IBD patients the risk of malignancy is of particular concern. We studied this risk in a population-based cohort of elderly onset IBD patients.METHODS: In a French population-based cohort, we identified 844 patients aged >60 years at IBD diagnosis from 1988 to 2006, including 370 Crohn's disease (CD) and 474 ulcerative colitis (UC). We compared incidence of cancer among IBD patients with that observed in the French Network of population-based Cancer Registries (FRANCIM). Confidence interval (CI) was estimated assuming a Poisson-specific law for ra…

MESH: CarcinomaMaleNonmelanoma Skin-CancerInflammatory bowel disease0302 clinical medicineAdrenal Cortex HormonesAzathioprineMESH: IncidenceAge of OnsetAged 80 and overeducation.field_of_studyMESH: Middle AgedRheumatoid-ArthritisIncidenceGastroenterologyMESH: Follow-Up StudiesMESH: Anti-Inflammatory Agents Non-Steroidal3. Good health030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatology[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: Immunosuppressive Agentsmedicine.medical_specialtyMESH: Age of OnsetMESH: Colitis Ulcerativedigestive systemMESH: Adrenal Cortex Hormones03 medical and health sciencesIntestinal NeoplasmsHumansCrohns-DiseaseeducationMESH: Intestinal NeoplasmsMESH: Protective FactorsMESH: AzathioprineAgedRetrospective StudiesMESH: HumansMESH: Crohn DiseaseTumor Necrosis Factor-alphaMESH: Retrospective Studiesmedicine.diseaseMESH: Inflammatory Bowel DiseasesInflammatory Bowel Diseasesdigestive system diseasesLymphoproliferative DisordersMethotrexateMESH: Tumor Necrosis Factor-alphaColitis UlcerativeComplicationMESH: FemaleProspective Observational CohortTime FactorsMESH: RegistriesMESH: Proportional Hazards ModelsMaintenance TherapyMESH: Aged 80 and overMESH: Lymphoproliferative DisordersCrohn DiseaseMESH: Risk FactorsRisk FactorsNeoplasmsMESH: NeoplasmsRegistriesUlcerative-ColitisMesalamineMESH: AgedIncidence (epidemiology)Anti-Inflammatory Agents Non-SteroidalMetaanalysisMiddle AgedhumanitiesMESH: MethotrexateFemaleFranceFrench PopulationColorectal NeoplasmsImmunosuppressive AgentsMESH: Myeloproliferative DisordersPopulationColorectal-CancerIncreased RiskInternal medicinemedicineProportional Hazards ModelsMyeloproliferative DisordersHepatologybusiness.industryMESH: Time FactorsCarcinomaCancerRetrospective cohort study[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMESH: MesalamineProtective FactorsMESH: MaleMESH: FranceAge of onsetbusinessMESH: Colorectal NeoplasmsFollow-Up StudiesThe American journal of gastroenterology
researchProduct

NMR study of magnetic order, metamagnetic transitions, and low-temperature spin freezing in Ca3Co2O6

2011

We report on a (59)Co NMR investigation of the trigonal cobaltate Ca(3)Co(2)O(6) carried out on a single crystal, providing precise determinations of the electric field gradient and chemical shift tensors, and of the internal magnetic fields at the nonmagnetic Co I sites, unavailable from former studies on powders. The magnetic-field-induced ferri-and ferromagnetic phases at intermediate temperature (e.g., 10 K) are identified by distinct internal fields, well accounted for by purely dipolar interactions. The vanishing transferred hyperfine field at the Co I site indicates that the Co(3+) (I) orbitals do not participate in the intrachain superexchange, in disagreement with a previous theore…

MagnetizationMaterials scienceCondensed matter physicsField (physics)FerromagnetismSuperexchangeCondensed Matter::Strongly Correlated ElectronsIsing modelCondensed Matter PhysicsHyperfine structureElectric field gradientElectronic Optical and Magnetic MaterialsMagnetic fieldPhysical Review B
researchProduct

An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake

2017

Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in the case of the brain, where the blood-brain barrier severely limits entry of drugs into the central nervous system. Nanoparticle-mediated transport of peptide/protein-based drugs across endothelial barriers shows great potential as a therapeutic strategy in a wide variety of diseases. Functionalizing nanoparticles with peptides allows for more efficient targeting to specific organs. We have evaluated the hemocompatibilty, cytotoxicity, endothelial uptake, efficacy of delivery and safety of liposome, hyperbranched polyester, poly(glycidol) and acrylamide-based nanoparticles functionalized wi…

Male0301 basic medicinePharmaceutical ScienceMedicine (miscellaneous)LIPOSOMES02 engineering and technologyPharmacologyDrug Delivery SystemsTissue DistributionGeneral Materials ScienceDENDRIMERSDRUG-DELIVERYCytotoxicityDrug CarriersLiposomeBrain021001 nanoscience & nanotechnologyMETHOTREXATEmedicine.anatomical_structureBlood-Brain BarrierDrug deliveryMolecular MedicineNanomedicine0210 nano-technologyMaterials scienceBiomedical EngineeringBioengineeringBlood–brain barrierMEDIATED TRANSPORTCell Line03 medical and health sciencesIn vivomedicineAnimalsHumansAmino Acid SequenceRats WistarDENDRITIC POLYMERSTargetingSENSITIVE HYDROGELSBiological TransportIn vitron/a OA procedure030104 developmental biologyNANOGELSNanoparticles for drug delivery to the brain80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLESCELLSNanoparticlesPeptides
researchProduct

Seasonal variation of BMI at admission in German adolescents with anorexia nervosa.

2018

Objective Recent preliminary studies indicated a seasonal association of BMI at admission to inpatient treatment for anorexia nervosa (AN), indicating lower BMI in the cold season for restrictive AN. An impaired thermoregulation was proposed as the causal factor, based on findings in animal models of AN. However, findings regarding seasonality of BMI and physical activity levels in the general population indicate lower BMI and higher physical activity in summer than in winter. Therefore, we aimed to thoroughly replicate the findings regarding seasonality of BMI at admission in patients with AN in this study. Method AN subtype, age- and gender-standardized BMI scores (BMI-SDS) at admission, …

Male050103 clinical psychologyAnorexia NervosaAdolescentPhotoperiodPopulationMedizinPhysical activitylcsh:Medicine610 Medicine & healthBody Mass Index03 medical and health sciences0302 clinical medicineGermanyMedicineHumans0501 psychology and cognitive sciencesClinical significanceRegistries610 Medicine & healtheducationlcsh:ScienceSubclinical infectioneducation.field_of_studyMultidisciplinarybusiness.industry05 social scienceslcsh:RSeasonalitymedicine.disease030227 psychiatryAnorexia nervosa (differential diagnoses)150 PsychologieSunshine durationSunlightlcsh:QFemaleSeasons150 PsychologybusinessBody mass indexDemographyPloS one
researchProduct

Prospective associations of early-onset Axis I disorders with developing eating disorders

2009

Objective: The purpose of this study is to analyze the developmental relationships of adolescent-onset Axis I mental disorders and eating disorders (EDs).Method: One thousand three hundred eighteen adolescent twins born from 1983 to 1987 completed a professionally administered semistructured psychiatric interview at the age of 14 years and a questionnaire follow-up at the age of 17.5 years.Results: Eating disorders at the age of 17.5 years were significantly predicted by major depressive disorder (odds ratio, 5.9; 95% confidence interval, 2.6-15.3) and generalized anxiety disorder (GAD) (odds ratio, 4.7; 95% confidence interval, 1.8-15.6) at the age of 14 years, when baseline EDs were exclu…

Male050103 clinical psychologySYMPTOMSSeverity of Illness Index0302 clinical medicineSurveys and Questionnaireslcsh:PsychiatryADOLESCENTSProspective StudiesRegistriesFinlandBulimia nervosa05 social sciencesAnxiety Disorders3. Good healthPsychiatry and Mental healthClinical PsychologyEating disordersTWINSGIRLSMajor depressive disorderAnxietyFemalemedicine.symptomPsychologymedicine.medical_specialtyANOREXIA-NERVOSAGeneralized anxiety disorderAdolescentlcsh:RC435-571generalized anxietyAGE 14QUESTIONNAIREArticleFeeding and Eating Disorders03 medical and health sciencesPrevalence of mental disordersBULIMIA-NERVOSAmedicineHumans0501 psychology and cognitive sciencesPsychiatryDepressive Disorder Majorfamilial factorsmedicine.diseaseComorbidity030227 psychiatryRISK-FACTORSadolescencesyömishäiriötAge of onsetmajor depressionCOMORBIDITYComprehensive Psychiatry
researchProduct

Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

2015

Introduction This work was undertaken to delineate intracellular signaling pathways for the PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate and adenosine A2A receptors (A2AR). Methods After apremilast and LPS incubation, intracellular cAMP, TNF-α, IL-10, IL-6 and IL-1α were measured in the Raw264.7 monocytic murine cell line. PKA, Epac1/2 (signaling intermediates for cAMP) and A2AR knockdowns were performed by shRNA transfection and interactions with A2AR and A2BR, as well as with methotrexate were tested in vitro and in the murine air pouch model. Statistical differences were determined using one or two-way ANOVA or Student’s t test. The alpha nominal…

MaleAdenosineReceptor Adenosine A2AImmunologyBlotting WesternAdenosine A2A receptorGene ExpressionPharmacologyBiologyCell LineMiceRheumatologyPhenethylaminesmedicineCyclic AMPImmunology and AllergyAnimalsGuanine Nucleotide Exchange FactorsReceptorIC50ArtritisReverse Transcriptase Polymerase Chain ReactionTumor Necrosis Factor-alphaMacrophagesAdenosineMolecular biologyCyclic AMP-Dependent Protein KinasesThalidomideMethotrexateMechanism of actionAntirheumatic AgentsCytokinesTumor necrosis factor alphaRNA InterferenceApremilastPhosphodiesterase 4 Inhibitorsmedicine.symptomInflammation MediatorsIntracellularMedicamentsmedicine.drugResearch Article
researchProduct